Virological and immunological responses to efavirenz or boosted lopinavir as first-line therapy for patients with HIV
Published inAntiviral therapy, vol. 14, no. 6, p. 771-779
Publication date2009
Abstract
Keywords
- Adult
- Anti-HIV Agents/administration & dosage/adverse effects/ therapeutic use
- Benzoxazines/administration & dosage/adverse effects/ therapeutic use
- Cohort Studies
- Female
- HIV Infections/ drug therapy
- Humans
- Male
- Prospective Studies
- Pyrimidinones/administration & dosage/adverse effects/ therapeutic use
Affiliation entities
Citation (ISO format)
YOUNG, Jim et al. Virological and immunological responses to efavirenz or boosted lopinavir as first-line therapy for patients with HIV. In: Antiviral therapy, 2009, vol. 14, n° 6, p. 771–779. doi: 10.3851/1291
Identifiers
- PID : unige:9486
- DOI : 10.3851/1291
- PMID : 19812439
Additional URL for this publicationhttp://www.intmedpress.com/journals/avt/abstract.cfm?id=1291&pid=88
Journal ISSN1359-6535